Editas Medicine Inc (FRA:8EM)
€ 1.262 0 (0%) Market Cap: 98.93 Mil Enterprise Value: -118.33 Mil PE Ratio: 0 PB Ratio: 0.57 GF Score: 47/100

Editas Medicine Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2021 / 01:30PM GMT
Release Date Price: €52.62 (-4.98%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. Good morning, everybody. Thanks for joining us here. I'm Matthew Harrison, one of the biotech analysts at Morgan Stanley. Very pleased to have Editas with us for the next session. Before we get started, I just need to read a disclosure statement. Please note that all-important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures. We've got the full crew with us. So we have Jim Mullen, CEO; Mark Shearman, CSO; and Lisa Michaels, CMO. So very pleased to have you all here, and thanks for joining us.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

I thought maybe a good place to start as you -- you recently spent some time at Cold Spring talking about some of the newer technologies that you're working on. So maybe just talk a little bit about SLEEK and why you've made some investments there and how you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot